Position in NVS
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$751,785
+$16,448 QoQ
Shares Held
4,797
-0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#723
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Essex Bank holds $41,161,477 across 11 Drug Manufacturers - General names. NVS ranks #7 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
67,809 | $17,221,451 | |
| 2 | LLY |
ELI LILLY & Co
|
10,367 | $12,434,490 | |
| 3 | MRK |
Merck & Co., Inc.
|
28,245 | $3,629,482 | |
| 4 | ABBV |
AbbVie Inc.
|
13,631 | $3,430,104 | |
| 5 | AMGN |
Amgen Inc
|
2,520 | $912,541 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
13,528 | $779,482 | |
| 7 | NVS |
Novartis AG
This page
|
4,797 | $751,785 | |
| 8 | PFE |
Pfizer Inc
|
24,466 | $589,140 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $751,785 | 4,797 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $735,337 | 4,814 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $663,430 | 4,812 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $591,314 | 4,611 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $557,976 | 4,611 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $504,558 | 4,526 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $382,914 | 3,935 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $444,321 | 3,863 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $283,502 | 2,663 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $316,694 | 3,274 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $330,575 | 3,274 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $260,251 | 2,555 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $257,824 | 2,555 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $240,948 | 2,619 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $236,325 | 2,605 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $224,913 | 2,959 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $218,002 | 2,579 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $226,482 | 2,581 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $228,646 | 2,614 | Shares | Sole | 2022-02-23 | |
| 2021-09-30 | $214,426 | 2,622 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $241,694 | 2,649 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $226,435 | 2,649 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $264,403 | 2,800 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $258,966 | 2,978 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $260,097 | 2,978 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $346,454 | 4,202 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||